Tg Therapeutics reported $-34887000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Amgen AMGN:US USD 3.04B 460M
Bayer BAYN:GR EUR 2.45B 2.31B
Biogen BIIB:US USD 992.8M 82.9M
Corcept Therapeutics CORT:US USD 32.13M 581K
Gilead Sciences GILD:US USD 2.7B 662M
Infinity Pharmaceuticals INFI:US USD -10770000 1.13M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
Johnson & Johnson JNJ:US USD 7.34B 1.2B
Karyopharm Therapeutics KPTI:US USD -30657000 12.1M
Novartis NOVN:VX USD 4.69B 34M
Ptc Therapeutics PTCT:US USD -33710000 29.47M
Roche Holding ROG:VX 13.44B 2.56B
Tg Therapeutics TGTX:US USD -34887000 3.98M
Verastem VSTM:US USD -17679000 3.69M
Vertex Pharmaceuticals VRTX:US USD 1.16B 6.8M